2 indicted in connection with counterfeit Ozempic scheme in Florida
Two Indian citizens are accused of smuggling counterfeit Ozempic to distributors in the U.S. at discounted prices.
Ozempic
GLP-1 drugs may help some women get hired
A study on the use of GLP-1 drugs shows they may be helping some women get ahead in their careers. CBS MoneyWatch reporter Megan Cerullo has more.
Dangers of unregulated weight-loss drug
Some doctors and nurses are promoting and prescribing the weight-loss drug retatrutide, which has not yet been approved by the U.S. Food and Drug Administration, a CBS News investigation found. Adam Yamaguchi has more.
"Ozempic breath" is boosting Hershey's sales of mints and gum
Hershey says it's benefiting from the growing use of GLP-1 weight-loss drugs even as people cut down on snacks. Here's why.
FDA warns Novo Nordisk over unreported potential Ozempic side effects
The FDA issued a warning letter to Novo Nordisk, the Danish drugmaker behind the diabetes and weight-loss medications Ozempic and Wegovy, over unreported potential side effects.
Novo Nordisk to slash Wegovy and Ozempic prices starting in 2027
Starting in 2027, the Danish pharma firm will sell its weight-loss and diabetes drugs for $675 per month.
New study on stopping weight loss drugs
Popular weight loss drugs like GLP-1 injections are helping millions of people lose pounds. But a new study shows that stopping these medications can cause the weight to rapidly come back and reverse positive health effects. CBS News medical contributor Dr. Céline Gounder has more.
Details on FDA-approved GLP-1 pill for weight loss
The FDA has approved the first GLP-1 pill for weight loss and it's expected in pharmacies in the coming weeks. Dr. Holly Lofton, director of the Medical Weight Management Program at NYU Langone, joins CBS News to discuss.
Measles entrenching in U.S., doctor says
A measles outbreak in South Carolina is worsening with 138 cases reported in the state. CBS News' Skyler Henry and Dr. Céline Gounder have more.
How GLP-1 drugs are shifting consumer habits
The rise in the use of GLP-1 weight-loss drugs across the U.S. is shifting not only scales, but also how Americans are spending their time and money. Washington Post retail reporter Jaclyn Peiser explains.
GLP-1 drugs and muscle loss: What to know
A recent KFF poll revealed that one in eight adults in the U.S. is currently taking a GLP-1 weight loss drug. As more people start using them, some are talking about the unexpected side effects, including muscle loss and weakness. Senior Vox correspondent Dylan Scott joins CBS News to share what patients told him.
Novo Nordisk slashes out-of-pocket prices for Wegovy and Ozempic
The Danish drugmaker said it's cutting the price of Wegovy and Ozempic from $499 to $349 per month for some customers who buy the drugs directly.
Details on lower weight loss drugs prices
President Trump announced a deal on Thursday that will lower the cost of some weight loss drugs for certain eligible Americans. CBS News medical contributor Dr. Celine Gounder explains the details of the deal and how much Americans can expect to pay.
Trump announces deal to lower weight loss drug prices in some cases
The deal, with Eli Lilly and Novo Nordisk, is expected to lower the price of obesity drugs to between $149 and $350 per month in some cases, officials said.
Trump unveils deal to cut weight loss drug prices
President Trump announced a deal to drastically lower the price of weight loss drugs for some Americans. Dr. Jon LaPook has more.
Novo Nordisk CEO on Trump drug prices deal
President Trump on Thursday unveiled agreements slashing the prices of two pharmaceutical companies' weight loss drugs. Novo Nordisk CEO Mike Doustdar joins "The Takeout" to unpack the cost-cutting effort.
Costco now sells Ozempic and Wegovy at its pharmacies
A one-month supply of Ozempic and Wegovy will now cost $499 out of pocket for Costco shoppers.
Costco to sell weight loss drugs
Shoppers can now find Ozempic and Wegovy at Costco. It says it is partnering with drugmaker Novo Nordisk to offer the drugs at a steep discount for members with a prescription. CBS News reporter Andres Gutierrez has more.
Drugs with weight loss side effects in demand
Medications that have a side effect of weight loss have seen a recent influx of popularity. Some manufacturers say they're having difficulty keeping up with increased demand as the medications become more normalized as a way to lose weight even though that's not the primary purpose for them. Dr. Lisa Palmer, a psychotherapist and founder of the Renew Center of Florida, joined CBS News to talk about the risks.
Inside the weight loss drug price war
The maker of Ozempic is cutting the price of the drug nearly in half for some patients. Novo Nordisk had already cut the price of Wegovy, a medication with the same active ingredient that's approved for weight loss. Dr. Celine Gounder has more on the emerging price competition over the drugs.
Positive results for new weight loss pill
Drugmaker Eli Lilly said Thursday that things are looking good for their latest weight loss drug that would be available as a pill. Dr. Jon LaPook reports.
Novo Nordisk ends Wegovy sales on Hims & Hers over "deceptive marketing"
Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the weight-loss drug.
Generic versions of Ozempic and Wegovy banned
Starting today, pharmacies can no longer make cheaper alternatives to popular weight loss drugs, driving up costs for millions. Dr. Celine Gounder joins to explain what this means for patients.
Patients fear losing affordable weight loss drugs
Weight loss drugs for many people may soon get a lot more expensive -- a shortage of them had actually led to lower prices. Kris Van Cleave explains how that happened and why prices could go up.
Zepbound tops Wegovy for weight loss in study comparing the drugs
Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, known as Ozempic and Wegovy, according to new research.
Tennessee prison system head to resign after failed Christa Pike execution
Jane Doe's attorney says "she was incapable of consent," alleges cover-up
Medical plane missing near Nantucket with 6 on board, authorities say
Live
Senior Trump administration officials met to discuss Iran war at Camp David
Iowa approves pricy foreign-owned steel plant project in swing district
More details emerge about FlyDubai co-pilot who tried to crash plane
U.K. police accuse 2 Iranian men of planning terror attack on Jewish community
Judge says federal law banning noncitizen voting is unconstitutional
